Prazosin Prevents Increased Anxiety Behavior That Occurs in Response to Stress During Alcohol Deprivations
- PMID: 27797712
- PMCID: PMC5169035
- DOI: 10.1093/alcalc/agw082
Prazosin Prevents Increased Anxiety Behavior That Occurs in Response to Stress During Alcohol Deprivations
Abstract
Aims: Stress-induced anxiety is a risk factor for relapse to alcohol drinking. The aim of this study was to test the hypothesis that the central nervous system (CNS)-active α1-adrenergic receptor antagonist, prazosin, would block the stress-induced increase in anxiety that occurs during alcohol deprivations.
Methods: Selectively bred male alcohol-preferring (P) rats were given three cycles of 5 days of ad libitum voluntary alcohol drinking interrupted by 2 days of alcohol deprivation, with or without 1 h of restraint stress 4 h after the start of each of the first two alcohol deprivation cycles. Prazosin (1.0 or 1.5 mg/kg, IP) or vehicle was administered before each restraint stress. Anxiety-like behavior during alcohol deprivation following the third 5-day cycle of alcohol drinking (7 days after the most recent restraint stress ± prazosin treatment) was measured by performance in an elevated plus-maze and in social approach/avoidance testing.
Results: Rats that received constant alcohol access, or alcohol access and deprivations without stress or prazosin treatments in the first two alcohol deprivations did not exhibit augmented anxiety-like behavior during the third deprivation. In contrast, rats that had been stressed during the first two alcohol deprivations exhibited increased anxiety-like behavior (compared with control rats) in both anxiety tests during the third deprivation. Prazosin given before stresses in the first two cycles of alcohol withdrawal prevented increased anxiety-like behavior during the third alcohol deprivation.
Conclusion: Prazosin treatment before stresses experienced during alcohol deprivations may prevent the increased anxiety during subsequent deprivation/abstinence that is a risk factor for relapse to alcohol drinking.
Short summary: Administration of prazosin before stresses during repetitive alcohol deprivations in male alcohol-preferring (P) rats prevents increased anxiety during a subsequent deprivation without further prazosin treatment. Prazosin treatment during repeated alcohol deprivations may prevent the increased anxiety that is a risk factor for relapse to alcohol drinking.
© The Author 2016. Medical Council on Alcohol and Oxford University Press. All rights reserved.
Figures




Similar articles
-
Drug challenges reveal differences in mediation of stress facilitation of voluntary alcohol drinking and withdrawal-induced anxiety in alcohol-preferring P rats.Alcohol Clin Exp Res. 2007 Sep;31(9):1473-81. doi: 10.1111/j.1530-0277.2007.00445.x. Epub 2007 Jul 11. Alcohol Clin Exp Res. 2007. PMID: 17624999 Free PMC article.
-
Chronic treatment with prazosin or duloxetine lessens concurrent anxiety-like behavior and alcohol intake: evidence of disrupted noradrenergic signaling in anxiety-related alcohol use.Brain Behav. 2014 Jul;4(4):468-83. doi: 10.1002/brb3.230. Epub 2014 Apr 14. Brain Behav. 2014. PMID: 25161814 Free PMC article.
-
Combining the α1 -adrenergic receptor antagonist, prazosin, with the β-adrenergic receptor antagonist, propranolol, reduces alcohol drinking more effectively than either drug alone.Alcohol Clin Exp Res. 2014 Jun;38(6):1532-9. doi: 10.1111/acer.12441. Epub 2014 May 30. Alcohol Clin Exp Res. 2014. PMID: 24891220 Free PMC article.
-
Prazosin Reduces Alcohol Intake in an Animal Model of Alcohol Relapse.Alcohol Clin Exp Res. 2015 Aug;39(8):1538-46. doi: 10.1111/acer.12789. Alcohol Clin Exp Res. 2015. PMID: 26207767 Free PMC article.
-
Alcohol dependence, withdrawal, and relapse.Alcohol Res Health. 2008;31(4):348-61. Alcohol Res Health. 2008. PMID: 23584009 Free PMC article. Review.
Cited by
-
Acute prazosin administration does not reduce stressor reactivity in healthy adults.Psychopharmacology (Berl). 2019 Nov;236(11):3371-3382. doi: 10.1007/s00213-019-05297-x. Epub 2019 Jun 13. Psychopharmacology (Berl). 2019. PMID: 31197436 Free PMC article. Clinical Trial.
-
Effects of chronic prazosin, an alpha-1 adrenergic antagonist, on anxiety-like behavior and cortisol levels in a chronic unpredictable stress model in zebrafish (Danio rerio).PeerJ. 2020 Jan 31;8:e8472. doi: 10.7717/peerj.8472. eCollection 2020. PeerJ. 2020. PMID: 32030326 Free PMC article.
-
Influence of stress associated with chronic alcohol exposure on drinking.Neuropharmacology. 2017 Aug 1;122:115-126. doi: 10.1016/j.neuropharm.2017.04.028. Epub 2017 Apr 19. Neuropharmacology. 2017. PMID: 28431971 Free PMC article. Review.
-
Noradrenaline Modulates Central Amygdala GABA Transmission and Alcohol Drinking in Female Rats.Biol Psychiatry. 2025 Apr 5:S0006-3223(25)01114-X. doi: 10.1016/j.biopsych.2025.03.024. Online ahead of print. Biol Psychiatry. 2025. PMID: 40194754 Free PMC article.
-
Medications for alcohol use disorders: An overview.Pharmacol Ther. 2018 May;185:64-85. doi: 10.1016/j.pharmthera.2017.11.007. Epub 2017 Dec 2. Pharmacol Ther. 2018. PMID: 29191394 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical